250 related articles for article (PubMed ID: 28482086)
1. Induction chemotherapy, extrapleural pneumonectomy and adjuvant radiotherapy for malignant pleural mesothelioma.
Casiraghi M; Maisonneuve P; Brambilla D; Solli P; Galetta D; Petrella F; Piperno G; De Marinis F; Spaggiari L
Eur J Cardiothorac Surg; 2017 Nov; 52(5):975-981. PubMed ID: 28482086
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
3. Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.
de Perrot M; Feld R; Cho BC; Bezjak A; Anraku M; Burkes R; Roberts H; Tsao MS; Leighl N; Keshavjee S; Johnston MR
J Clin Oncol; 2009 Mar; 27(9):1413-8. PubMed ID: 19224855
[TBL] [Abstract][Full Text] [Related]
4. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial).
Hasegawa S; Okada M; Tanaka F; Yamanaka T; Soejima T; Kamikonya N; Tsujimura T; Fukuoka K; Yokoi K; Nakano T
Int J Clin Oncol; 2016 Jun; 21(3):523-30. PubMed ID: 26577445
[TBL] [Abstract][Full Text] [Related]
5. Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.
Nelson DB; Rice DC; Mitchell KG; Tsao AS; Gomez DR; Sepesi B; Mehran RJ
J Thorac Cardiovasc Surg; 2019 Sep; 158(3):924-929. PubMed ID: 31430846
[TBL] [Abstract][Full Text] [Related]
6. Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial.
Van Schil PE; Baas P; Gaafar R; Maat AP; Van de Pol M; Hasan B; Klomp HM; Abdelrahman AM; Welch J; van Meerbeeck JP;
Eur Respir J; 2010 Dec; 36(6):1362-9. PubMed ID: 20525721
[TBL] [Abstract][Full Text] [Related]
7. Outcome for patients with malignant pleural mesothelioma referred for Trimodality therapy in Western Australia.
Hasani A; Alvarez JM; Wyatt JM; Bydder S; Millward M; Byrne M; Musk AW; Nowak AK
J Thorac Oncol; 2009 Aug; 4(8):1010-6. PubMed ID: 19546819
[TBL] [Abstract][Full Text] [Related]
8. Impact of induction therapy on postoperative outcome after extrapleural pneumonectomy for malignant pleural mesothelioma: does induction-accelerated hemithoracic radiation increase the surgical risk?
Mordant P; McRae K; Cho J; Keshavjee S; Waddell TK; Feld R; de Perrot M
Eur J Cardiothorac Surg; 2016 Sep; 50(3):433-8. PubMed ID: 27005976
[TBL] [Abstract][Full Text] [Related]
9. Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Toxicity and outcomes at an Australian institution.
Bece A; Tin MM; Martin D; Lin R; McLean J; McCaughan B
J Med Imaging Radiat Oncol; 2015 Jun; 59(3):355-62. PubMed ID: 25753747
[TBL] [Abstract][Full Text] [Related]
10. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
[TBL] [Abstract][Full Text] [Related]
12. Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy.
Thieke C; Nicolay NH; Sterzing F; Hoffmann H; Roeder F; Safi S; Debus J; Huber PE
Radiat Oncol; 2015 Dec; 10():267. PubMed ID: 26715491
[TBL] [Abstract][Full Text] [Related]
13. Trimodality treatment of malignant pleural mesothelioma.
Batirel HF; Metintas M; Caglar HB; Yildizeli B; Lacin T; Bostanci K; Akgul AG; Evman S; Yuksel M
J Thorac Oncol; 2008 May; 3(5):499-504. PubMed ID: 18449002
[TBL] [Abstract][Full Text] [Related]
14. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
Sugarbaker DJ; Flores RM; Jaklitsch MT; Richards WG; Strauss GM; Corson JM; DeCamp MM; Swanson SJ; Bueno R; Lukanich JM; Baldini EH; Mentzer SJ
J Thorac Cardiovasc Surg; 1999 Jan; 117(1):54-63; discussion 63-5. PubMed ID: 9869758
[TBL] [Abstract][Full Text] [Related]
15. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine followed by adjuvant chemotherapy in patients with malignant pleural mesothelioma.
Lang-Lazdunski L; Bille A; Belcher E; Cane P; Landau D; Steele J; Taylor H; Spicer J
J Thorac Oncol; 2011 Oct; 6(10):1746-52. PubMed ID: 21876457
[TBL] [Abstract][Full Text] [Related]
16. Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: experience of Guy's and St Thomas' hospitals.
Bille A; Belcher E; Raubenheimer H; Landau D; Cane P; Spicer J; Lang-Lazdunski L
Gen Thorac Cardiovasc Surg; 2012 May; 60(5):289-96. PubMed ID: 22453539
[TBL] [Abstract][Full Text] [Related]
17. Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma.
Baldini EH; Richards WG; Gill RR; Goodman BM; Winfrey OK; Eisen HM; Mak RH; Chen AB; Kozono DE; Bueno R; Sugarbaker DJ
J Thorac Cardiovasc Surg; 2015 May; 149(5):1374-81. PubMed ID: 25772281
[TBL] [Abstract][Full Text] [Related]
18. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.
Lang-Lazdunski L; Bille A; Papa S; Marshall S; Lal R; Galeone C; Landau D; Steele J; Spicer J
J Thorac Cardiovasc Surg; 2015 Feb; 149(2):558-65; discussion 565-6. PubMed ID: 25726878
[TBL] [Abstract][Full Text] [Related]
19. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
[TBL] [Abstract][Full Text] [Related]
20. Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma.
Krug LM; Pass HI; Rusch VW; Kindler HL; Sugarbaker DJ; Rosenzweig KE; Flores R; Friedberg JS; Pisters K; Monberg M; Obasaju CK; Vogelzang NJ
J Clin Oncol; 2009 Jun; 27(18):3007-13. PubMed ID: 19364962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
